Search

Search Constraints

You searched for: Author/Creator Hammer, Gary D

Search Results

2. Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study. Issue 4 (April 2015)

3. Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study. Issue 4 (April 2015)

4. Somatic mutations in adrenocortical carcinoma with primary aldosteronism or hyperreninemic hyperaldosteronism. Issue 2 (February 2019)